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Adriamycin cardiotoxicity has been correlated with a disturbance of heart mitochondrial functions. Here, 
Siminodaunorubicin was compared with adriamycin for its capability to interfere in the mitochondrial 
electron transport with subsequent membrane damaging. The results suggest hat minor chemical 
modifications of the anthraquinone moiety of anthracycline glycoside drugs should be a promising way 
to decrease mitochondrial membrane damage induced by this class of antitumor drugs. 
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1. INTRODUCTION 
Chemotherapeutic usefulness of adriamycin 
(ADM) (fig. la) and derivatives, members of the 
antitumor anthracyclines class, is limited by a uni- 
que cardiotoxicity [l]. Many reports correlate this 
cardiotoxicity of ADM with a disturbance of heart 
mitochondrial functions and ATP synthesis [2-51. 
In [6] we showed that the anthraquinone moiety of 
the ADM molecule catalyses electron transport 
from NADH to cytochrome c. This resulted in an 
enhanced chemical reactivity of ADM with forma- 
tion of covalent-like linkage with membrane com- 
ponents and subsequent membrane damage most 
likely due to polymerization of chemically ac- 
tivated phospholipids (free radicals, peroxides). 
Binding of ADM on cardiolipin (CL), a 
phospholipid specific of the inner mitochondrial 
membrane, was a prerequisite since the strong elec- 
trostatic complex ADM-CL [6] has a ubiquinone- 
* To whom correspondence should be addressed 
like structure capable to replace native ubiquinone 
as membraneous electron transporter. 
This paper tests the new ADM derivatives 
modified in their anthraquinone ring to decrease 
their capability to transport electrons. 
5-Iminodaunorubicin (WDRB) (fig. lb) was com- 
pared with ADM for its capability to interfere in 
the mitochondrial electron transport with subse- 
quent membrane damaging. 
2. MATERIALS AND METHODS 
NADH (grade III), beef heart cardiolipin, com- 
plex I-III and cytochrome c were purchased from 
Sigma. 1-6 Diphenylhexatriene (DPH) was an 
Aldrich product and NaN3 a Merck product. 
Adriamycin and 5-iminodaunorubicin were pro- 
vided by the National Cancer Institute. All 
chemicals were of analytical grade and water was 
triple-distilled. Fluorescence polarization 
measurements were performed on an Elscint 
. . . 
Mlcrovlscoslmeter MVI,. Absorbance measure- 
ments were realized on a Shimadzu UV-190 double 
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Fig. 1. Structure of (a) adriamycin (ADM); (b) 5-iminodaunorubicin (5-IDRB). 
beam spectrophotometer, thermostatized at 25°C. 
The vibration electrode technique was employed to 
measure the surface potential [7]. For all ex- 
periments, Tris-HCl lo-’ M buffer (pH 7.4) con- 
taining 50 mM NaN3 was used. 
Mitochondrial membranes were extracted from 
beef heart as in [8]. They were stored at - 20°C for 
several weeks without loss of activity. Complex 
I-III was assayed for its NADH-cyt. c oxidoreduc- 
tase activity by following cyt. c reduction at 
550 nm. Multilamellar proteoliposomes were ob- 
tained by dispersing the dry lipid film with a 
purified enzyme suspension [9]. Liposome suspen- 
sion was not sonicated in order to avoid enzyme 
damage. In this procedure, an ethanolic solution 
of cardiolipin was evaporated under nitrogen, and 
then dispersed in Tris-HCl buffer with proteins. 
The drug, both electrostatically and covalently 
bound to cardiolipin, can be extracted by a CHCl3 
phase. To distinguish between the two types of 
binding, the electrostatically bound drug was first 
dissociated by 6 M CaCl2 [lo]. 
3. RESULTS 
Since the ability of an ADM derivative to in- 
terfere with mitochondrial electron transport is 
related to its capability to form an electrostatic 
complex with CL [l 11, we first measured the 
association constant between 5-IDRB and CL. 
This was carried out by measuring the surface 
potential of a monolayer of CL mixed with DPPC, 
a neutral phospholipid inert towards 5-IDRB. If 
we consider the reaction between an anionic site of 
CL (P-) and the positively ionized drug (D+), one 
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can write: 
D+ + P- = DP 
with an association constant: 
WI UOO-U 1 
K= 
[D+],[P-] = ___ u [D’ls 
(1) 
(2) 
where: 
g and CO = the surface charge density after and 
[Dls = 
before complexation, respectively; 
the molar concentration of D+ at the 
interface. 
[D’ls is related to the bulk concentration through 
a Boltzmann distribution: 
[D’ls = [D$, exp (- e#/k7) (3) 
where: 
e = the electronic charge; 
k = the Boltzmann constant; 
+ = the negative surface potential after com- 
plexation. 
From a general point of view, the electrostatic 
potential # (mV) associated to the lipid monolayer 
is described by the Gouy-Chapman theory. At 
25°C: 
$ = 50.4 s/r-’ (134 &/C) (4) 
where: 
u = the surface charge density in charge/A2; 
C = the molar salt concentration in the solution. 
To determine the surface charge density of the 
monolayer after the drug has been added (c) in the 
subphase, we increased IO-times the [Na+] of the 
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bulk by injecting an appropriate amount of a 
saturated NaNO3 solution into the subphase. The 
increase of the surface potential A(A& after the 
Na+ injection is related to g by relation 5 [ 121. At 
25°C: 
OD change 
at 550 “In 
A@+) = 50.4 (&-’ 134 - s/r-’ =) 
s fl 
(5) 
where: 
Ci and Cz are the concentrations in monovalent 
ions before and after NaNO3 injection, 
respectively; 
Ci was chosen equal to lo-* M/l and C2 equal to 
10-l M/l. For a detailed discussion on this surface 
potential technique see [ 121. Results are reported in 
table 1. 
K-Value for ADM is in good agreement with the 
value determined in [l 11. The K-values found for 
ADM and 5-IDRB are of the same order of 
Table 1 
Association constant and surface potential data of the 
ADM-CL and 5-IDRB-CL complex 
ADM 5-IDRB 
A(Wa 17 mV 25 mV 
ueb 5.53 x lo-’ 5.53 x 1o-3 
(charge/A2) (charge/A2) 
a= 3.93 x 1o-4 6.18 x 1o-4 
(charge/A’) (charge/A2) 
4+d 8 mV 13 mV 
[D+]me lo-’ M lo-’ M 
]D+ls 1.38 x 1O-5 M 1.60 x 1O-5 M 
KB 1 x 1O-6 l/M 2 x 1O-5 l/M 
a Experimental values of the increase of the surface 
potential following Na+ injection 
b 00 is determined by the monolayer composition. A 
CL/DPPC molar ratio of 27JlOO was chosen. 
Considering an area/molecule of 60 A2 for DPPC 
(uncharged) and 120 A2 for CL (bearing two negative 
charges) for a close-packed monolayer, a~ was 
calculated 
’ Determined from A(A+), eq. (5) with the use of a 
numerical technique developed in [12] 
d From (T using eq. (4) 
’ Chosen equal to 1 x low5 M/l for ADM and 1 x 
10m5 M/l for 5-IDRB 
f From [D+], using eq. (3) 
g Equation (2) 
Fig.2. Effect of ADM and 5-IDRB on the rate of 
electron transport between NADH and cyt. c in a 
mitochondrial suspension 6 x 10m3 mg protein/ml. 
Cytochrome c was: 0.7 mg/ml; Tris-HCl 10v2 M buffer 
@H 7.4) containing 50 mM NaNr was used. 
magnitude. The effect of ADM and 5-IDRB on the 
electron transport between NADH and cyt. c was 
therefore tested on extracted beef heart mitochon- 
dria. Fig.2 shows that ADM increases the rate of 
electron flow between NADH and cyt. c by -80070, 
whereas in presence of 5-IDRB no increase is 
observed. Even a slight decrease was recorded. To 
test the chemical reactivity of the drug towards the 
membrane, proteoliposomes of CL and purified 
NADH-cyt. c oxidoreductase were incubated with 
the drug in presence or in absence of NADH. The 
fact that even in presence of 6 M/l Ca*+ (in this 
condition the electrostatic complex is dissociated 
[lo]) the water-soluble drug is extracted from the 
aqueous phase into a chloroform phase in partition 
experiments, suggests the formation of a covalent 
linkage between the drug and CL. Results are 
reported in table 2. The amount of drug was 
evaluated spectrophotometrically. 
Clearly, 5-IDRB remains much more chemically 
inert than ADM. Do the above described 
phenomena modify the membrane properties? A 
possible way to evaluate a general modification of 
the membrane properties is to measure the 
fluorescence depolarization of a dye embedded in 
the membrane. The fluorescence depolarization P 
can be correlated to the membrane viscosity [ 131. 
We first measured P using the fluorescence of the 
drug itself on proteoliposomes containing CL, 
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Table 2 
Formation of a new linkage between drug and CL as a 
consequence of the electron flow between NADH and 
cyt. c 
- NADH + NADH 
ADM extracted with 
chloroform 
S-IDRB extracted with 
0% 81% 
chloroform 0% 3% 
The values in percent represent the excess of drug 
extracted by chloroform in the conditions described 
below as compared to a simple system containing only 
buffer, chloroform and the drug. In this system, the 
amount of drug extracted by chloroform is only 1% for 
ADM and 16% for SIDRB. Multilamellar 
proteoliposomes were obtained by dispersing the lipid 
film (CL) with Tris-HCI buffer (pH 7.4) containing the 
purified enzyme (NADH-cyt. c oxidoreductase). 
Proteoliposomes 1 mg CL/ml, 6.25 units of NADH-cyt. 
c oxidoreductase were incubated for 3 h with the drug 
2 x 10e4 M in the presence or absence of NADH 1.2 x 
lo-’ M. After incubation, excess of drug and NADH 
was eliminated by centrifugation of the proteoliposomes 
(10 min, 800 x g) followed by 5 washings. The bound 
drug was estimated as in section 2 
NADH-cyt. c oxidoreductase and the drug in the 
presence or in absence of NADH. When 5-IDRB 
was used, Ps-rDRB -values were almost independent 
on the incubation in presence of NADH. However, 
when ADM was used, a dramatic increase of pDM 
was observed (table 3). As both a decrease of the 
membrane fluidity or a decrease of the life-time of 
the excited state of the chemically modified ADM 
molecule can account for the pDM increase, we 
can only conclude that the ADM membrane system 
was dramatically modified after incubation in the 
presence of NADH, whereas the 5-IDRB mem- 
brane system was not. More quantitative data 
about the membrane viscosity were obtained by 
measuring the P-value of diphenylhexatriene 
(DPH), a classical probe of the membrane fluidity. 
Incubation of proteoliposomes with NADH did 
not modify the PnPH when 5-IDRB was used. 
However, a large increase of PnPH was recorded 
when ADM was used. As the DPH molecule has 
not been modified since it was added at the end of 
the reaction, the increase of PnPH must correspond 
to a loss of mobility of DPH which can be cor- 
related to a rigidification of its environment. It 
must be pointed out from table 3 that in the 
absence of NADH, PnpH is significantly different 
for proteoliposomes containing 5-IDRB or ADM. 
DnPH in the presence of ADM corresponds to 
PnPH in the absence of drug demonstrating that 
ADM does not perturb the microviscosity of the 
membrane. This is in good agreement with 
preceding data which showed that ADM is exclud- 
ed from the hydrophobic part of the bilayer [ 111. 
Table 3 
Effect of electron transport between NADH and cyt. c on fluorescence depolarization of drugs and DPH 
plmg 
pDpn 
P is defined as: 
Proteoliposomes 
+ ADM 
0.070 
0.190 
Proteoliposomes 
+ ADM + NADH 
0.163 
0.226 
Proteoliposomes 
+ 5-IDRB 
0.096 
0.217 
Proteoliposomes 
+ 5-IDRB + NADH 
0.090 
0.219 
P = (II - I,)/(I, + I,) 
where I, and I, are the fluorescence intensities polarized parallel and perpendicular to the direction of polarization of 
the excitation 
Precision on P-values, 0.004; PDF-H without drug, 0.190. In fluorescence depolarization experiments, proteoliposomes 
(2.13 mg CL/ml; 2.33 mg mitochondrial protein/ml were incubated for 24 h with the drug (ADM or 5-IDRB) 3 x 
10m4 M in the presence or absence of NADH (20 mg/ml). After the incubation, proteoliposomes were washed 5-times 
by centrifugation, then diluted to obtain a constant fluorescence intensity. This solution was incubated with DPH 
(0.6 pg DPH/ml mitochondrial suspension) and diluted 20-times. At this concentration, only DPH gave a measurable 
signal 
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Fig.3. Hypothetical reactions of the anthraquinone moiety of ADM during electron transport. 
On the other hand, the slight rigidification observ- 
ed in the presence of 5-IDRB means that this drug 
modifies the movement of the phospholipid hydro- 
carbon chain. 
4. DISCUSSION 
We have shown here that ADM is capable of 
facilitating electron transport between NADH and 
cyt. c in the inner mitochondrial membrane 
whereas 5-IDRB is not. The difference of 
behaviour between ADM and 5-IDRB can in fact 
not arise from a different ability to form the elec- 
trostatic complex with CL [l l] since the measured 
association constants of the drug-CL complex 
were of the same order of magnitude for both 
drugs. We therefore tentatively attributed the elec- 
tron transport through ADM to the reaction 
described in fig.3. 
The consequences of the electron transport 
through ADM are: 
(i) An enhancement of ADM chemical reactivity 
followed by a covalent-like binding to CL 
(table 2); 
(ii) A damaging of the membrane properties 
(microviscosity) (table 3). 
Adriamycin radicals are spontaneously formed 
by adriamycin solution at physiological pH 
whereas 5-IDRB does not form semiquinone 
radicals [ 141. It is likely that ADM-free radicals 
enhance mitochondrial lipids peroxidation as has 
been already observed on other membrane systems 
[15-191. As we know that peroxidized 
phospholipids can undergo polymerization reac- 
tions [20,21] (and therefore increase of membrane 
microviscosity) and that the inner mitochondrial 
membrane is very sensitive to the peroxidation of 
its phospholipids [22], it is not surprising that 
ADM-mediated electron transport affects so 
drastically the mitochondrial membrane [2-51. Re- 
cent studies seem to confirm that in fact 5-IDRB is 
much less cardiotoxic than ADM [23,24]. The 
cumulative dose of 5-IDRB required to produce 
significant widening of the QRS complex in the rat 
electrocardiogram, was 6-times the cumulative 
dose of ADM [25]. It was confirmed that 5-IDRB 
did not induce irreversible changes in the vacuole 
ultrastructure of myocardiac cells of rats. These 
changes were caused by an equal dose of ADM 
1231. 
Our results strongly suggest that the ADM 
quinone function is essential to induce mitochon- 
drial membrane damage and that minor modifica- 
tions at this level could modify strongly the 
cytotoxicity. 
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